STOCKS TELEGRAPH

Tag: BNGO

  • Bionano Genomics Inc (BNGO) stock lost 8.8% in the after-market. Here’s why

    The stock of Bionano Genomics Inc (BNGO) closed the recent trading session at $2.16, 0.93% more than the previous trading session. On the last check, the stock of BNGO followed a bearish pattern in the after-market, losing 8.8% to $1.97. BNGO published the financial performance for its Q4 and FY21.

    BNGO’s FY21 performance

    On 1 March 2022, Bionano Genomics published the financial performance for the period Q4 and FY21, which ended on 31 December 2021. The company posted revenue of $6.3 million in Q4 of FY21 compared to $3.9 million in the corresponding period of last year. This marks a growth of 57.9%. The yearly revenue expanded by 111.4% to $17.9 million in 2021 from $8.5 million in 2020. Total loss of BNGO grew by 95.6% in Q4 of FY21 to $22.9 million versus $11.7 million in Q4 of FY20. The yearly loss expanded by 76.2% in 2021 to $72.4 million. BNGO’s operating loss increased by 158.7% in Q4 of FY21 to $28.7 million against $11.1 million in the same year-ago period. Also, the yearly operating loss expanded by 99.9% in 2021 to $77.1 million.

    The company sold 12,518 flow cells in the fiscal year 2021. The Saphyr system of the company grew by 14% to 164 bases in Q4 of FY21 versus 141 bases in Q4 of FY20. Further, BNGO finished the principal model for the single-molecule imaging framework for OGM. Moreover, Bionano obtained BioDiscovery, Inc, including its industry-driving software, NxClinical.

    CEO Remarks

    The CEO of Bionano Genomics, Erik Holmlin, stated that they accept 2021 was ground-breaking for Bionano. He further added that they added top-notch software through the addition of BioDiscovery and fundamentally improved their programming aptitude.

    Mr. Holmlin concluded that they start in 2022 hoping to proceed with the energy that is enhanced throughout 2021.

    About BNGO

    Bionano Genomics (BNGO) is a supplier of genome investigation arrangements. The investigations can empower analysts and clinicians to further uncover answers to inquiries in medication. The company has a market cap of $624.6 million and 289.18 million pending shares. BNGO have a headquarter in San Diego, California, the United States of America (USA),

  • Why Bionano Genomics, Inc. (BNGO) stock is rising today?

    Bionano Genomics, Inc. (BNGO) announced today that the two large laboratories of the United Kingdom have adopted its Saphyr System for optical genome mapping after which the BNGO stock price saw a push of 3.72% to reach $5.58 a share at the time of this writing. BNGO stock went up in the previous closing by 2.09% with a $5.38 per share price. Let’s deep dive to explore more of it.

    What’s happening?

    Investors are responding to the recent news announced by Bionano stock today related to its Saphyr system adopted by two large laboratories in U.K. NHS Regional Genetics Laboratory in Belfast City Hospital and King’s College Hospital in London have adopted the Saphyr system of Bionano stock via its reagent rental program in which consumable are purchased over time subjective to the placement of the system. Both libraries are using the Saphyr System to diagnose heme malignancies through the timely identification of genomic structural variants of patients. The laboratory in Belfast will also use this system for various other rare and genetic diseases.

    Recent Previous Activity:

    BNGO stock on April 14, 2021, did announce the launching of an IRB-approved preclinical evaluation study by the Foundation for Embryonic Competence (FEC)  pursuant to which FEC will use optical genome mapping (OGM) with the Saphyr system of Bionano stock in order to perform the analysis of genomes of couples who have gone through the repeated pregnancy loss or recurrent embryo implantation failure. The purpose of this study is to compare the performance of improved resolution of OGM with the traditional methods for the identification of structural rearrangement in connection with testing of embryos before implantation.

    Financial View of BNGO stock:

    In the fourth quarter of 2020, BNGO stock generated $4.0 million in revenue which represents a 43% increase as compared to the same period of 2019. The total fiscal revenue of 2020 was reduced to $8.5 million in 2020 from $10.1 million in 2019 due to limitations in laboratory operations by Bionano’s customers due to COVID-19.

    Conclusion:

    It seems that momentum was already built for the BNGO stock and its recent news has added more hype to the rising stock price. The recent developments show that the BNGO stock is growing day by day. Hence it can be a good bet for investors in the long run.

  • Early Morning Vibes: 4 Stocks We Like for Friday

    Early Morning Vibes: 4 Stocks We Like for Friday

    On January 14, the American stock indices closed in the red. The S&P 500 index dropped 0.38% to 3796 points, the NASDAQ dropped 0.12%, the Dow Jones lost 0.22%. The weakening of optimism was due to macrostats. The number of initial applications for unemployment benefits for the week unexpectedly rose to the highest in five months. However, the flow of capital to small-cap stocks continued, with the Russel 2000 up 2.05%. The energy sector was again the leader of growth (+ 3.01%), while the IT sector was down 0.95% under the influence of weak performance in FAANG shares.

    Corporate news

    Delta Air Lines (DAL: + 2.5%) quarterly report was stronger than investors expected as revenue outperformed forecast.

    BlackRock (BLK: -4.7%) posted better-than-expected revenue and bottom line, but capital inflows to funds were weak.

    Semiconductor manufacturer Taiwan Semiconductor Manufacturing (TSM: + 6.1%) raised its forecast for average revenue growth over the next five years to 10-15% from 5-10%. TSM’s quarterly report was overall better than forecast.

    Global stock markets are showing mixed dynamics. President-elect Joe Biden has unveiled a $ 1.9 trillion bailout package that will be funded by increasing government debt. The bulk of this amount will go to help households, including through direct payments to Americans in the amount of $ 1400. About $ 400 billion is expected to be allocated to fight the virus and a vaccination campaign. In February, Biden will unveil an addendum to the announced plan that will include infrastructure costs. However, investors were not too encouraged by this: S&P 500 futures are showing a slight decline. This is partly due to the fact that the presented program almost coincided with the expectations of market participants, who, at the same time, would like to hear more details about infrastructure costs.

    The scale of monetary stimulus, most likely, will not start to decrease soon. Fed Chairman Jerome Powell reiterated yesterday that rates will not be raised for a long time. The first hike is still expected in 2023. Powell noted that the Fed will start signaling plans to scale back its asset purchase program in advance.

    December retail sales data will be released today. A decrease of 0.2% m / m is expected after falling by 1.1% in November, which is associated with the preservation of a number of quarantine measures in the United States, restricting, in particular, the work of the catering sector. The data for January should reflect the effect of direct payments to the population at the end of December.

    JPMorgan Chase & Co (JPM) will report for the past quarter today. Earnings per share, according to general market expectations, should increase by 3.89% YoY to $ 2.67, and the bank’s non-interest segment revenue will increase by about 20% yoy. This rapid growth will be driven by increased operational activity in investment banking and trading. The bank’s net interest margin is forecast to plateau in the third quarter, so a trend reversal is likely in the fourth quarter report on the back of rising 10-year US government bond yields.

    Sentiment Index

    Sentiment Index from Freedom Finance unchanged at around 58 out of 100. The indicator reflects the hope of market participants for a recovery in the global economy in 2021. Concerns about the negative impact of the coronavirus pandemic are diminishing thanks to the prospect of mass vaccinations.

    Technical picture

    Technically, the S&P 500 is still prone to short-term consolidation. During yesterday’s session, the broad market index tested its maximum and corrected. There is a risk of formation of a “double top” pattern, which will be conducive to correction. The RSI indicator remains close to the overbought zone, which limits the growth prospects.

    Today Top Movers

    BlackBerry Ltd (BB), a Software – Infrastructure company, soared about 19.65% ‎at $10.90 in pre-market trading Friday after the news of the patent sale to Huawei.‎

    ‎Bionano Genomics Inc (BNGO) share price jumped 11.07% to $7.72 during the early morning ‎trading session on Friday.‎ The firm recently revealed that day three of its five-day Next-Generation Cytogenomics Symposium featured six Saphyr users presenting their results and experiences using the Saphyr® system for optical genome mapping (OGM) to analyze solid tumor genomes.

    Tilray Inc (TLRY) stock ascended 5.82% at $19.64 in the pre-market trading today.

    Sundial Growers Inc (SNDL) gained over 2.72% at $0.71 in pre-market ‎trading on Friday.‎ The firm lately revealed the launch of premium concentrates products under its top leaf brand.

    Top Upgrades & Downgrades

    Stifel turned bullish on Elastic N.V. (ESTC), upgrading the stock to “Buy” and assigning a $180.0 price target, representing a potential upside of 17.26% from Thursday’s close. 

    Raymond James Financial Inc. (RJF) has won the favor of Wells Fargo’s equity research team. The firm upgraded the shares from Underweight to Overweight and moved their price target to $120.0, suggesting 16.87% additional upside for the stock. 

    Emerson Electric Co. (EMR) received an upgrade from analysts at UBS, who also set their one-year price target on the stock to $100.0. They changed their rating on EMR to Buy from Neutral in a recently issued research note. 

    Earlier Friday KeyBanc reduced its rating on Axalta Coating Systems Ltd. (AXTA) stock to Sector Weight from Overweight. 

    BofA analysts reduced their investment ratings, saying in research reports covered by the media that its rating for Vishay Intertechnology Inc (NYSE: VSH) has been changed to Underperform from Neutral. 

    Analysts at Barclays downgraded Everbridge Inc (NASDAQ: EVBG)’s stock to Neutral from Outperform Friday.

    Latest Insider Activity

    Wayfair Inc. (W) Chief Technology Officer Miller James R. announced the sale of shares taking place on Jan 13 at $300.00 for some 1,500 shares. The total came to more than $0.45 million. 

    GAN Limited (GAN) EVP, Chief Commercial Officer Berman Jeffrey Bruce sold on Jan 12 a total 60,000 shares at $24.00 on average. The insider’s sale generated proceeds of almost $1.44 million. 

    Aldeyra Therapeutics Inc. (ALDX) 10% Owner PERCEPTIVE ADVISORS LLC declared the purchase of shares taking place on Jan 08 at $9.34 for some 550,000 shares. The transaction amount was around $5.14 million. 

    At Home Group Inc. (HOME) 10% Owner SOSIN CLIFFORD bought on Jan 06 a total 11,078,735 shares at $17.55 on average. The purchase cost the insider an estimated $4.83 million.

    Important Earnings

    Top US earnings releases scheduled for today include Citigroup Inc. (NYSE:C). It will announce its Dec 2020 financial results. The company is expected to report earnings of $1.34 per share from revenues of $16.71B in the three-month period. 

    Analysts expect Wells Fargo & Company (NYSE:WFC) to report a net income (adjusted) of $0.6 per share, when the bank releases its quarterly results shortly. Revenue for the fiscal quarter ended Dec 2020 is predicted to come in at $18.13B. 

    JPMorgan Chase & Co. (JPM), due to announce earnings before the market opens today, is expected to report earnings of $2.62 per share from revenues of $28.7B recently concluded three-month period.

  • 26 stocks trending in pre-market

    ‎Bionano Genomics Inc. (BNGO) stock soared 13.81% to $2.39 in the pre-‎market ‎trading following an announcement from the firm that Nasdaq has granted the Company an ‎additional ‎‎180-day compliance period, or until June 28, 2021. The most recent rating by Ladenburg ‎Thalmann, on ‎September 24, 2020, is a Buy. ‎

    Before the trading started on December 31, 2020, fuboTV Inc. (FUBO) is down -‎‎‎2.43% to reach $32.5. It has been trading in a 52-week range of $5.00 to $62.29.‎

    ‎Guardion Health Sciences Inc. (NASDAQ: GHSI) shares are trading down -10.77% ‎at ‎‎$0.5247 at the time of writing. The firm lately revealed the appointment of Bret Scholtes as ‎its ‎President and Chief Executive Officer, and as a member of the Board of Directors. Company’s 52-‎week ‎ranged between $0.17 to $0.74.‎

    ‎Nxt-ID Inc. (NXTD) stock soared 7.1% to $1.81 in the pre-market trading. ‎The ‎most ‎recent rating by Maxim Group, on November 20, 2017, is a Buy.‎

    ‎Castor Maritime Inc. (CTRM) grew over 41.75% at $0.33 in pre-market trading ‎today ‎after receiving 180-day extension from Nasdaq to meet Nasdaq minimum bid price rule. ‎

    ‎Net Element Inc. (NASDAQ: NETE) shares are trading down -5.21% at $15.45 at ‎the ‎time of writing. Company’s 52-week ranged between $1.47 to $20.08. ‎

    ‎Sundial Growers Inc. (SNDL) stock moved down -1.36 percent to $0.4784 in the pre-‎‎market trading following the declaration from the company that it has closed the acquisition of ‎a ‎special purpose vehicle. ‎

    ‎Professional Diversity Network Inc. (IPDN) gained over 14.96% at $3.15 in pre-‎‎market trading Thursday December 31, 2020 after the firm revealed its partnership with ‎Phala ‎Network.‎

    ‎Marathon Patent Group Inc. (MARA) is up more than 7.63% at $11.71 in pre-‎market ‎hours Thursday December 31, 2020. The company recently revealed that it has entered into a ‎contract ‎with Bitmain to purchase 70,000 Antminer S-19 ASIC miners. The stock had dropped over -‎‎7.48% to ‎‎$10.88 in the last trading session.‎

    ‎Riot Blockchain Inc. (RIOT), a Software – Application company, rose about ‎‎4.92% ‎at ‎‎$18.11 in pre-market trading Thursday.‎

    ‎Nano Dimension Ltd. (NNDM) stock moved up 2.09 percent to $9.75 in the pre-‎‎market trading after closing $250 million registered direct offering.‎

    ‎AIkido Pharma Inc. (AIKI) gained over 33.72% at $1.15 in pre-‎‎market ‎trading ‎Thursday December 31, 2020.‎

    ‎Color Star Technology Co. Ltd. (NASDAQ: CSCW) shares are trading down -4.38% ‎at ‎‎$0.8032 at the time of writing after declaring strategic partnership with two UAE ‎companies. ‎Company’s 52-week ranged between $0.31 to $2.06.‎

    ‎IMAC Holdings Inc. (IMAC) stock moved down -4.08 percent to $1.41 in the pre-‎‎market trading after reporting completion of first infusion of Stem Cells in clinical study for ‎the ‎treatment of Bradykinesia due to Parkinson’s disease.‎

    ‎Ampio Pharmaceuticals Inc. (AMPE) stock soared 12.84% to $1.67 in the pre-‎market ‎trading. The firm recently revealed that it has received guidance from the U.S Food & ‎Drug ‎Administration regarding the impact of COVID-19 on its Phase III clinical trial for osteoarthritis of ‎the ‎knee. The most recent rating by ROTH Capital, on December 19, 2019, is a Buy.‎

    ‎Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) shares are trading up 5.76% ‎at ‎‎$49.4 at the time of writing after the company announced that it would develop a therapeutic spray ‎as ‎a candidate to treat the hereditary lung and digestive-system disease cystic fibrosis. Company’s 52-‎‎week ranged between $8.51 to $129.71. Analysts have a consensus price target of $69. ‎

    Before the trading started on December 31, 2020, Baidu Inc. (BIDU) is up ‎‎3.53% ‎to ‎reach $227.38. It has been trading in a 52-week range of $82.00 to $202.79.‎

    ‎Greenpro Capital Corp. (GRNQ) is up more than 3.11% at $1.99 in pre-market ‎hours ‎Thursday December 31, 2020. The company lately revealed that it intends to set up a Bitcoin ‎‎($BTC) ‎Fund for investment. The stock had jumped over 3.76% to $1.93 in the last trading session.‎

    ‎Onconova Therapeutics Inc. (ONTX) is down more than -3.79% at $0.49 in pre-‎‎market hours Thursday December 31, 2020. The stock had jumped over 18.88% to $0.51 in the ‎last ‎trading session.‎

    ‎JinkoSolar Holding Co. Ltd. (JKS) grew over 2.28% at $65.55 in pre-market ‎trading ‎today. The firm recently revealed annual general meeting 2020 ‎results.‎

    ‎Tonix Pharmaceuticals Holding Corp. (TNXP) lost over -2.76% at $0.6632 in pre-‎‎market trading Thursday December 31, 2020.‎

    ‎Osmotica Pharmaceuticals plc (OSMT) stock moved down -2.13 percent to $4.14 ‎in ‎the pre-market trading after declaring that the U.S. Food and Drug Administration (FDA) has ‎declined ‎to approve one of its products. ‎

    ‎Cinedigm Corp. (CIDM) is down more than -0.69% at $0.62 in pre-‎market ‎hours ‎Thursday December 31, 2020. The stock had dropped over -9.51% to $0.62 in the last ‎trading ‎session.‎

    ‎Novan Inc. (NOVN), a Biotechnology company, dropped about -7.71% at $0.969 ‎in ‎pre-market trading Thursday.‎

    Before the trading started on December 31, 2020, Canaan Inc. (CAN) is ‎up ‎‎25.57% ‎to ‎reach $5.5. It has been trading in a 52-week range of $1.76 to $8.69.‎

    ‎500.com Limited (WBAI) gained over 5.12% at $8.0 in pre-market trading ‎Thursday ‎December 31, 2020. The company recently declared that Mr. Zhaofu Tian has resigned as ‎Chief ‎Technology Officer of the Company due to personal reasons.‎

  • 23 Stocks Making Sharp Moves in Pre Market Session

    23 Stocks Making Sharp Moves in Pre Market Session

    ‎Bionano Genomics Inc. (BNGO) stock soared 46.62% to $1.95 in the pre-‎market ‎trading after reporting that Praxis Genomics, LLC received accreditation from the College of ‎American ‎Pathologists (CAP). The most recent rating by Ladenburg Thalmann, on September 24, 2020, ‎is a Buy.‎

    ‎Tenax Therapeutics Inc. (NASDAQ: TENX) shares are trading down -7.07% at $1.84 ‎at ‎the time of writing. Company’s 52-week ranged between $0.25 to $2.68.‎

    ‎Ideanomics Inc. (IDEX) stock soared 2.87% to $2.15 in the pre-market trading. ‎The ‎company recently revealed that its Mobile Energy Global (“MEG”) and its contracting entity ‎Qingdao ‎Chengyang Medici have signed an agreement with Meihao Chuxing, a joint venture between ‎BYD and ‎Didi, to purchase an initial 2,000 units of model BYD D1. ‎

    ‎Oxbridge Re Holdings Limited (OXBR) stock moved down -6.83 percent to $1.91 ‎in ‎the pre-market trading.‎

    ‎Guardion Health Sciences Inc. (NASDAQ: GHSI) shares are trading up 12.48% ‎at ‎‎$0.4289 at the time of writing. The firm lately declared the appointment of seasoned ‎nutritional ‎products industry leader Bret Scholtes as President and Chief Executive Officer. Company’s ‎‎52-week ‎ranged between $0.17 to $0.74.‎

    ‎Gevo Inc. (GEVO) is down more than -4.76% at $4.4 in pre-market ‎hours ‎Wednesday December 30, 2020. The stock had dropped over -4.15% to $4.62 in the last ‎trading ‎session.‎

    ‎Universal Security Instruments Inc. (UUU) stock moved up 5.0 percent to $5.25 ‎in ‎the pre-market trading following its statement regarding recent market activity in the ‎Company’s ‎stock.‎

    ‎Marathon Patent Group Inc. (MARA) gained over 10.03% at $12.94 in pre-‎market ‎trading Wednesday December 30, 2020. The company recently reported that it has entered ‎into a ‎contract with Bitmain to purchase 70,000 Antminer S-19 ASIC miners.‎

    Before the trading started on December 30, 2020, Ocugen Inc. (OCGN) is down -‎‎‎7.83% to reach $2.0. It has been trading in a 52-week range of $0.17 to $3.05.‎

    Before the trading started on December 30, 2020, Moderna Inc. (MRNA) is ‎up ‎‎3.59% to reach $118.5 following the declaration from the company that the it is engaged in ‎discussions ‎with the government of South Korea to potentially provide 40 million or more doses of the ‎Moderna ‎COVID-19 Vaccine to support South Korea’s aim of providing vaccines to the public as soon as ‎possible. ‎It has been trading in a 52-week range of $17.68 to $178.50.‎

    ‎Riot Blockchain Inc. (RIOT) stock soared 6.02% to $16.74 in the pre-market trading.‎

    ‎Technical Communications Corporation (NASDAQ: TCCO) shares are trading down -‎‎‎16.78% at $4.76 at the time of writing after declaring its results for the fiscal year ended September ‎‎26, ‎‎2020. Company’s 52-week ranged between $1.72 to $7.00.‎

    ‎Tonix Pharmaceuticals Holding Corp. (TNXP) is up more than 2.21% at $0.6695 ‎in ‎pre-market hours Wednesday December 30, 2020. The stock had dropped over -6.16% to $0.65 in ‎the ‎last trading session.‎

    ‎AstraZeneca PLC (AZN) gained over 2.26% at $51.03 in pre-market ‎trading ‎Wednesday December 30, 2020 after receiving approval of its coronavirus vaccine in U.K.‎

    ‎New Concept Energy Inc. (AMEX: GBR) shares are trading down -14.75% at $2.08 ‎at ‎the time of writing. Company’s 52-week ranged between $0.55 to $2.19.‎

    ‎Moleculin Biotech Inc. (MBRX) stock plunged -1.67% to $0.8279 in the pre-‎market ‎trading after declaring that that the US Food and Drug Administration (FDA) has granted ‎Orphan Drug ‎Designation (ODD) to Annamycin for treatment of soft tissue sarcomas.‎

    ‎MoSys Inc. (MOSY), a Semiconductors company, dropped about -13.22% at $2.1 ‎in ‎pre-market trading Wednesday.‎

    Before the trading started on December 30, 2020, Greenpro Capital Corp. (GRNQ) ‎is ‎down -2.15% to reach $1.82. The company lately revealed that it intends to set up a Bitcoin ‎‎($BTC) ‎Fund for investment. It has been trading in a 52-week range of $0.21 to $3.12.‎

    ‎Nxt-ID Inc. (NXTD) gained over 9.92% at $1.44 in pre-market trading ‎Wednesday ‎December 30, 2020.‎

    ‎Hepion Pharmaceuticals Inc. (HEPA) gained over 50.0% at $3.12 in pre-‎market ‎trading Wednesday December 30, 2020 after declaring positive top line data for low dose ‎CRV431 in ‎Phase 2a ‘AMBITION’ clinical trial for treatment of Advanced NASH.‎

    ‎XPeng Inc. (XPEV) is up more than 3.13% at $42.85 in pre-market hours ‎Wednesday ‎December 30, 2020. The stock had jumped over 9.31% to $41.55 in the last trading session.‎

    ‎BioNTech SE (BNTX) is up more than 3.5% at $91.37 in pre-market hours ‎Wednesday ‎December 30, 2020 following declaration from the financial magazine Caixin that Shanghai ‎Fosun ‎Pharmaceutical Group will set up a joint venture with BioNTech to produce COVID-19 vaccines in ‎China. ‎The stock had jumped over 0.19% to $88.28 in the last trading session.‎

    Before the trading started on December 30, 2020, Bit Digital Inc. (BTBT) is up ‎‎14.58% ‎to reach $12.1. It has been trading in a 52-week range of $0.28 to $12.45.‎

  • Market Movers: What changed for these 21 stocks while you were sleeping

    Market Movers: What changed for these 21 stocks while you were sleeping

    ‎Greenpro Capital Corp. (GRNQ), a Conglomerates company, dropped about -‎‎5.88% ‎at $1.76 in pre-market trading Tuesday after announcing Bitcoin fund.‎

    ‎ATIF Holdings Limited (ATIF) stock plunged -8.51% to $0.9698 in the pre-‎market ‎trading.‎

    ‎Bionano Genomics Inc. (BNGO) stock soared 8.57% to $0.96 in the pre-‎market ‎trading after declaring that Praxis Genomics, LLC received accreditation from the College of ‎American ‎Pathologists (CAP). The most recent rating by Ladenburg Thalmann, on September 24, 2020, ‎is a Buy. ‎

    ‎Zomedica Corp. (AMEX: ZOM) shares are trading up 4.5% at $0.2625 at the ‎time ‎of ‎writing. Company’s 52-week ranged between $0.06 to $0.50.‎

    ‎Nano Dimension Ltd. (NASDAQ: NNDM) shares are trading up 5.52% at $8.6 at ‎the ‎time of writing after pricing $250 million registered direct offering. ‎Company’s 52-week ‎ranged ‎between $0.51 to $10.49. Analysts have a consensus price target of $8. ‎

    ‎Jaguar Health Inc. (JAGX) stock moved down -2.88 percent to $0.7325 in the pre-‎‎market trading.‎

    ‎Ideanomics Inc. (IDEX), a Software – Application company, rose about 4.27% at ‎‎$2.44 ‎in pre-market trading Tuesday following the declaration the signing of an agreement of its ‎Mobile ‎Energy Global (“MEG”) and contracting entity Qingdao Chengyang Medici with Meihao ‎Chuxing, a joint ‎venture between BYD and Didi, to purchase an initial 2,000 units of model BYD D1. ‎

    ‎Alibaba Group Holding Limited (BABA) is up more than 3.64% at $230.45 in pre-‎‎‎market hours Tuesday December 29, 2020. The stock had jumped over 0.16% to $222.36 in ‎the ‎last ‎trading session.‎

    Before the trading started on December 29, 2020, FuelCell Energy Inc. (FCEL) is ‎up ‎‎2.3% to reach $11.81. It has been trading in a 52-week range of $0.84 to $13.91.‎

    ‎AeroCentury Corp. (ACY) lost over -25.7% at $10.29 in pre-market trading ‎Tuesday ‎December 29, 2020 following the update of listing standards compliance.‎

    ‎Color Star Technology Co. Ltd. (CSCW) is down more than -9.21% at $0.69 in pre-‎‎‎market hours Tuesday December 29, 2020. The stock had jumped over 7.04% to $0.76 in ‎the ‎last ‎trading session.‎

    Before the trading started on December 29, 2020, Guardion Health Sciences ‎Inc. ‎‎(GHSI) is up 14.83% to reach $0.36. The firm recently reported the appointment of ‎Bret ‎Scholtes, as its President and Chief Executive Officer, and as a member of the Board of Directors. ‎He is ‎a veteran of the nutritional products industry for nearly a decade. It has been trading in a 52-‎week ‎range of $0.17 to $0.74.‎

    ‎Nokia Corporation (NOK) stock soared 2.31% to $3.99 in the pre-market ‎trading ‎after reporting that it has been selected by Thailand’s dtac as its first 5G partner.‎ The most ‎recent ‎rating by Exane BNP Paribas, on October 30, 2020, is a Neutral. ‎

    Before the trading started on December 29, 2020, Acasti Pharma Inc. (ACST) is ‎up ‎‎7.32% to reach $0.3343. It has been trading in a 52-week range of $0.17 to $2.75.‎

    ‎RMG Acquisition Corp. (RMG) grew over 2.1% at $32.61 in pre-market trading ‎today ‎following the stockholder approval of business combination with Romeo Systems, Inc. with ‎no ‎redemptions.‎

    ‎Aprea Therapeutics Inc. (APRE), a Biotechnology company, rose about 4.73% ‎at ‎‎$5.76 in pre-market trading Tuesday after declaring results of primary endpoint from Phase 3 trial ‎of ‎Eprenetapopt in TP53 Mutant Myelodysplastic Syndromes (MDS).‎

    ‎MicroVision Inc. (NASDAQ: MVIS) shares are trading up 6.41% at $7.14 at ‎the ‎time ‎of writing. Company’s 52-week ranged between $0.15 to $9.74. Analysts have a consensus ‎price ‎target ‎of $4.50.‎

    ‎China Recycling Energy Corporation (CREG) is down more than -2.23% at $5.7 in pre-‎‎market hours Tuesday December 29, 2020 after revealing that it has entered into agreement to ‎acquire ‎Xi’an Taiying Energy Saving Technology ‎Co., Ltd..‎. The stock had jumped over 31.31% to $5.83 in ‎the last ‎trading session. ‎

    ‎BIOLASE Inc. (BIOL) stock moved up 25.44 percent to $0.6021 in the pre-‎market ‎trading.‎

    ‎Borr Drilling Limited (BORR), a Oil & Gas Drilling company, rose about 4.66% ‎at ‎‎$0.854 in pre-market trading Tuesday after reporting the appointment of Mr. Magnus Vaaler as its ‎new ‎Chief Financial Officer. He will replace Mr. Christoph Bausch.‎

    ‎Onconova Therapeutics Inc. (NASDAQ: ONTX) shares are trading up 3.68% ‎at ‎‎$0.465 ‎at the time of writing. Company’s 52-week ranged between $0.19 to $1.56. Analysts have ‎a ‎consensus ‎price target of $7.50.‎

  • Pre-Market Cues: 29 Stocks Roaring for Change On December 24th

    Pre-Market Cues: 29 Stocks Roaring for Change On December 24th

    ‎Ocugen Inc. (OCGN) stock plunged -8.85% to $2.37 in the pre-market trading after ‎reporting the appointment of a vaccine scientific advisory board comprised of leading academic and ‎industry experts in the vaccine field.‎

    ‎Sundial Growers Inc. (SNDL), a Drug Manufacturers – Specialty & Generic ‎company, ‎dropped about -3.24% at $0.4838 in pre-market trading Thursday.‎

    ‎Jaguar Health Inc. (NASDAQ: JAGX) shares are trading down -22.43% at $0.83 at the ‎time of writing after signing second agreement for $6 million non-dilutive financing transaction ‎involving the sale of royalty rights related to future Mytesi (Crofelemer) and Lechlemer revenue ‎Sstream. Company’s 52-week ranged between $0.19 to $1.08. Analysts have a consensus price target ‎of $2. ‎

    ‎Onconova Therapeutics Inc. (ONTX) stock moved down -7.92 percent to ‎‎$0.465 ‎in ‎the pre-market trading.‎

    ‎Acasti Pharma Inc. (ACST) tumbled over -4.77% at $0.4095 in pre-market trading ‎today following the announcement from the company that the Company’s management and Board of ‎Directors are unaware of any material change in the Company’s operations that would account for the ‎recent increase in market activity.‎

    ‎FuelCell Energy Inc. (FCEL) lost over -4.55% at $12.81 in pre-‎market ‎trading ‎Thursday ‎December 24, 2020.‎

    ‎Bionano Genomics Inc. (NASDAQ: BNGO) shares are trading down -3.87% at $0.745 ‎at the time of writing after the company announced publication revealing in side-by-side comparison ‎that method using PacBio sequencing ‎detects only 72% of the large structural variants detected by ‎optical Genome Mapping with Saphyr.‎ Company’s 52-week ranged between $0.25 to $1.39. Analysts ‎have a consensus price target of $1.25. ‎

    ‎Marathon Patent Group Inc. (NASDAQ: MARA) shares are trading ‎up ‎‎7.31% ‎at ‎‎$11.6 ‎at the time of writing. Company’s 52-week ranged between $0.35 to ‎‎$14.08. ‎Analysts ‎have ‎a ‎consensus price target of $7.50.‎

    ‎Zomedica Corp. (ZOM) is down more than -2.48% at $0.22 in pre-‎‎‎market ‎hours ‎Thursday December 24, 2020. The stock had jumped over 17.50% to $0.23 in ‎the ‎last ‎trading ‎session.‎

    ‎Nano Dimension Ltd. (NNDM) is up more than 7.18% at $9.4 in pre-‎‎market ‎hours ‎Thursday December 24, 2020. The stock had dropped over -3.41% to $8.77 in the ‎last ‎trading ‎session.‎

    Before the trading started on December 24, 2020, Senseonics Holdings Inc. (SENS) is ‎up 79.29% to reach $1.16 following its declaration of financial and operational business updates. It has ‎been trading in a 52-week range of $0.35 to $1.78.‎

    ‎Corbus Pharmaceuticals Holdings Inc. (CRBP) lost over -2.08% at $1.41 in pre-‎‎market ‎trading Thursday December 24, 2020.‎

    Before the trading started on December 24, 2020, Foresight Autonomous ‎Holdings ‎Ltd. ‎‎(FRSX) is down -20.87% to reach $4.55. It has been trading in a 52-week range ‎of $0.46 ‎to ‎‎$3.40.‎

    ‎Canaan Inc. (CAN) is up more than 2.12% at $3.85 in pre-‎market ‎hours ‎Thursday ‎December 24, 2020. The stock had dropped over -8.94% to $3.77 in the last ‎trading ‎session.‎

    ‎Avinger Inc. (AVGR) stock soared 76.25% to $0.61 in the pre-market trading after ‎reporting results of its annual meeting of stockholders. The most recent rating by Ladenburg ‎Thalmann, on March 09, 2018, is a Buy.‎

    ‎Triterras Inc. (NASDAQ: TRIT) shares are trading up 16.58% at $14.06 ‎at ‎the ‎time ‎of ‎writing. Company’s 52-week ranged between $7.70 to $15.17. Analysts have ‎a ‎consensus ‎price ‎target ‎of $23.‎

    ‎Tantech Holdings Ltd (TANH), a Household & Personal Products ‎company, ‎rose ‎about 3.29% at $1.57 in pre-market trading Thursday.‎

    ‎Tonix Pharmaceuticals Holding Corp. (TNXP) grew over 36.36% at $0.9 in pre-market ‎trading today following the announcement from the firm that it has completed the purchase of an ‎approximately 44-acre site in Hamilton, Montana, for the construction of a vaccine development and ‎commercial scale manufacturing facility. ‎

    ‎Gold Resource Corporation (GORO) stock moved down -6.85 percent to ‎‎$3.4 ‎in ‎the ‎pre-market trading.‎

    ‎Nikola Corporation (NKLA) gained over 1.8% at $15.3 in pre-market trading ‎Thursday December 24, 2020. The company reported, on Wednesday, that Nikola and Republic ‎Services (RSG) have discontinued their collaboration on refuse truck development.‎

    ‎Molecular Data Inc. (MKD) gained over 2.94% at $0.9027 in pre-‎‎‎market ‎trading ‎Thursday December 24, 2020.‎

    ‎Gevo Inc. (GEVO), a Specialty Chemicals company, rose about 1.03% at $2.94 in pre-‎‎‎‎‎‎market trading Thursday.‎

    ‎IZEA Worldwide Inc. (NASDAQ: IZEA) shares are trading up 3.9% at $1.6 at the time ‎of writing after reporting that it has set a Managed Services bookings record for the best Q4 in ‎company history. Company’s 52-week ranged between $0.07 to $3.13. IZEA Managed Services ‎Bookings Top 40% Growth in Q4 to Hit Record.‎

    ‎Novan Inc. (NOVN) grew over 6.81% at $0.737 in pre-market trading today.‎

    Before the trading started on December 24, 2020, ReWalk Robotics Ltd. (RWLK) is ‎up 9.2% to reach $1.9. The firm recently revealed that it has donated one of its ReStore Exo-suits to ‎Brooks Rehabilitation, located in Jacksonville, Florida. It has been trading in a 52-week range of $0.41 to ‎‎$2.71.‎

    ‎Inuvo Inc. (AMEX: INUV) shares are trading up 2.16% at $0.52 at the ‎time ‎of ‎writing. ‎Company’s 52-week ranged between $0.09 to $1.11. Analysts have a consensus price ‎target ‎of ‎‎$2.25.‎

    ‎Aurora Mobile Limited (JG) stock soared 8.16% to $4.11 in the pre-market trading ‎following the announcement of a partnership deal with Taikang Life Insurance Co., Ltd., to strengthen ‎smart insurance solutions with AI rechnologies. The most recent rating by Goldman, on March 06, ‎‎2019, is a Neutral.‎

    ‎fuboTV Inc. (FUBO) stock soared 3.73% to $54.55 in the pre-market ‎trading. ‎The ‎most recent rating by BMO Capital Markets, on December 23, 2020, is a Market perform.‎

    ‎Farmmi Inc. (FAMI) is down more than -2.61% at $1.12 in pre-market hours ‎Thursday December 24, 2020. The company recently revealed its sales win to multi-channel ‎customers with over 100 retail stores in China and Canada. The stock had jumped over 1.77% to $1.15 ‎in the last trading session.‎

  • 15 Trending Stocks To Watch In Diagnostics And Research Industry

    15 Trending Stocks To Watch In Diagnostics And Research Industry

    The Diagnostic Research Industry is playing an integral part in the medical evaluation and treatment of patients.  This industry is vital to the healthcare market as it is providing information related to the severity and causes of illnesses in patients to healthcare practitioners. The changes we are witnessing in today’s healthcare industry are setting the goal for evolution we will see over the next decade.

    There are major drivers that are changing and will change the direction of this industry in present and future as well. The first driver is technology. As time passes by, new technologies are emerging and playing a very important role in the healthcare industry. In today’s world, patients want easier access to care and demand better service. The demand for this industry is linked to the number of patients receiving the treatment. The profitability and growth of the company depend on good marketing and efficient operations.

    Let check these 15 companies in Diagnostic Research Industry to know more about this industry and the trends this industry is following:

    Interpace Biosciences Inc. (NASDAQ: IDXG)

    Interpace Biosciences Inc. (NASDAQ: IDXG) shares were trading up 32.89% at $3.96 at the time of writing on Wednesday. Interpace Biosciences Inc. (NASDAQ: IDXG) share price went from a low point around $2.57 to briefly over $11.00 in the past 52 weeks, though shares have since pulled back to $3.96. IDXG market cap has remained high, hitting $15.88M at the time of writing, giving it a price-to-sales ratio of more than 0.

    Interpace Biosciences Inc. (NASDAQ: IDXG) has announced that the Audit Committee has disclosed the result of an independent investigation. The committee has completed the investigation with the statement that the allegations made in the complaints were unverified and there is no truth behind them. investigation and If we look at the recent analyst rating IDXG, Janney initiated coverage on IDXG shares with a Buy rating.

    OPKO Health Inc. (NASDAQ: OPK)

    OPKO Health Inc. (NASDAQ: OPK) last closed at $4.07, in a 52-week range of $1.12 to $6.47. Analysts have a consensus price target of $8.00. OPKO Health Inc. (OPK) disclosed it plans to report operating and financial results for the three months ended September 30, 2020, as well as discuss financial guidance, after the close of the U.S. financial markets on Thursday, October 29, 2020.

    Invitae Corporation (NYSE: NVTA)

    Invitae Corporation (NYSE: NVTA) stock drop by -6.29% to $49.28. The most recent rating by JP Morgan, on October 14, 2020, is at a Neutral. Invitae Corporation (NVTA) disclosed that on October 2, 2020, it has executed the transaction to bring ArcherDX into Invitae to create a comprehensive offering that provides testing services for disease risk, therapy optimization, and personalized cancer monitoring to enable precision approaches to cancer treatment.

    Pacific Biosciences of California Inc. (NASDAQ: PACB)

    Pacific Biosciences of California Inc. (NASDAQ: PACB) shares headed rising, higher as much as 0.07%. The most recent rating by JP Morgan, on October 02, 2020, is at an Overweight. Pacific Biosciences of California Inc. (PACB) has disclosed that collaborated with Children’s Mercy Kansas City to further understand the most challenging pediatric diseases. The companies will join forces to sequence a statistically significant cohort of rare disease cases for which previous whole-genome and whole-exome sequencing studies yielded no answers.

    Bionano Genomics Inc. (NASDAQ: BNGO)

    Bionano Genomics Inc. (NASDAQ: BNGO) fall -0.15% after losing more than $0.0 on Wednesday. Bionano Genomics Inc. (BNGO) revealed today that it is scheduled to release financial results of the third quarter ended September  30, 2020, on November 12, 2020. The company will also hold the conference call on the same day.

    T2 Biosystems Inc. (NASDAQ: TTOO)

    T2 Biosystems Inc. (NASDAQ: TTOO) stock drop by 0.00% to $1.33 after T2 Biosystems to Report Third Quarter 2020 Financial Results on November 4, 2020. The most recent rating by BTIG Research, on October 08, 2020, is at a Buy.  T2 Biosystems Inc. (TTOO) market capitalization has remained high, hitting $196.79 million at the time of writing.

    NeoGenomics Inc. (NASDAQ: NEO)

    NeoGenomics Inc. (NASDAQ: NEO) Shares headed rising, higher as much as 5.46%. The most recent rating by Morgan Stanley, on September 09, 2020, is at an Overweight. NeoGenomics Inc. (NEO) revealed its plans to open a state-of-the-art research laboratory in China in association with the new lab PPD, Inc. (NASDAQ: PPD) is opening in Suzhou.

    PerkinElmer Inc. (NYSE: PKI)

    PerkinElmer Inc. (NYSE: PKI) fall -2.10% after losing more than -$2.62 on Wednesday. PerkinElmer Inc. (PKI) earlier announced that it is expected to report organic revenue growth of approximately 35% and 33%, respectively, for the third quarter ended October 4, 2020.

    Chembio Diagnostics Inc. (NASDAQ: CEMI)

    Chembio Diagnostics Inc. (NASDAQ: CEMI) last closed at $4.77, in a 52-week range of $2.25 to $15.89. Analysts have a consensus price target of $5.00. Chembio Diagnostics Inc. (CEMI) disclosed earlier that the U.S. Food and Drug Administration (FDA) has approved the Premarket Approval (PMA) application for the DPP HIV-Syphilis System.

    Illumina Inc. (NASDAQ: ILMN)

    Illumina Inc. (NASDAQ: ILMN) Shares headed falling, lower as much as -4.35%. The most recent rating by Guggenheim, on October 13, 2020, is at a Neutral. Illumina Inc. (ILMN) has earlier announced that it is scheduled to release the third quarter 2020 following the close of the market on Thursday, October 29, 2020.

    Enzo Biochem Inc. (NYSE: ENZ)

    Enzo Biochem Inc. (NYSE: ENZ) fall -17.24% after losing more than -$0.45 on Wednesday. Enzo Biochem Inc. (ENZ) earlier reported financial results for the fourth quarter and full-year ended July 31, 2020, and provided a business update on recent corporate and operational developments.

    Fulgent Genetics Inc. (NASDAQ: FLGT)

    Fulgent Genetics Inc. (NASDAQ: FLGT) last closed at $38.17, in a 52-week range of $6.70 to $52.47. Analysts have a consensus price target of $56.25. Fulgent Genetics Inc. (FLGT) disclosed earlier that the Ohio Department of Rehabilitation and Correction (“ODRC”) has selected Fulgent Genetics for their COVID-19 testing needs.

    QIAGEN N.V. (NYSE: QGEN)

    QIAGEN N.V. (NYSE: QGEN) stock drop by -0.11% to $52.37. The most recent rating by BofA Securities, on October 06, 2020, is at a Buy. QIAGEN N.V. (QGEN) earlier announced preliminary sales and adjusted earnings per share (EPS) results for the third quarter of 2020. It has shared that the Net sales grew 26% at actual rates, and also rose 26% at constant exchange rates (CER) $481.3 million from $382.7 million in the same period of 2019.

    Fluidigm Corporation (NASDAQ: FLDM)

    Fluidigm Corporation (NASDAQ: FLDM) last closed at $6.89, in a 52-week range of $1.17 to $12.45. Fluidigm Corporation (FLDM) has moved up 488.03% from its 52-weeks low and moved down -44.74% from its 52-weeks high. Looking at its liquidity, it has a current ratio of $509.65 million at the time of writing.

    Danaher Corporation (NYSE: DHR)

    Danaher Corporation (NYSE: DHR) stock soar by 0.41% to $226.55. The most recent rating by Wolfe Research, on June 16, 2020, is at an Outperform. Danaher Corporation (DHR) share price went from a low point around $119.60 to briefly over $227.48 in the past 52 weeks, though shares have since pulled back to $222.59. DHR  market cap has remained high, hitting $156.91 billion at the time of writing.

     

     

  • 10 Of The Best Diagnostics Research Industry Stocks To Buy For 2020

    10 Of The Best Diagnostics Research Industry Stocks To Buy For 2020

    Healthcare is a dynamic and opportunity-rich industry. The demand for innovations that brings improvement in health outcomes, affordability, quality, and access will continue to be high. The changes we witnessed in the healthcare industry today have set a new tone for the change in the coming few years. 2020 is the year of change for the health care industry.

    The first thing which played an important role in the healthcare industry is Technology. Technology is continuously changing and brings new improvement in the healthcare industry. Patients today want easier and affordable access to care and better demand services. In this changing environment, diagnostics is emerging as a key driver in helping to address these needs.

    Here are the top 10 leading companies in Diagnostics Research Industry that need your attention:

    OPKO Health Inc. (NASDAQ: OPK)

    OPKO Health Inc. (NASDAQ: OPK) shares were trading down -0.92% at $3.22 at the time of writing on Tuesday. OPKO Health Inc. (NASDAQ: OPK) share price went from a low point around $1.12 to briefly over $6.47 in the past 52 weeks, though shares have since pulled back to $3.22. OPK market cap has remained high, hitting $2.13B at the time of writing, giving it a price-to-sales ratio of more than 2.

    OPKO Health Inc. has earlier started a Phase 2 trial with RAYALDEE as a treatment for mild-to-moderate COVID-19.  If we look at the recent analyst rating OPK, Piper Jaffray initiated coverage on OPK shares with an Overweight rating.

    Pacific Biosciences of California Inc. (NASDAQ: PACB)

    Pacific Biosciences of California Inc. (NASDAQ: PACB) last closed at $8.78, in a 52-week range of $2.20 to $8.38. Analysts have a consensus price target of $6.50. Pacific Biosciences of California Inc. (PACB) has announced it has appointed Susan G. Kim as Chief Financial Officer. The decision is effective as of September 28, 2020. Susan has joined the company at a time when there are various growth opportunities for the company.

    Bionano Genomics Inc. (NASDAQ: BNGO)

    Bionano Genomics Inc. (NASDAQ: BNGO) stock soar by 0.79% to $0.64. The most recent rating by Oppenheimer, on April 08, 2020, is at an Outperform. Bionano Genomics Inc. (BNGO) will participate in the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit. the summit is scheduled to take place virtually on September 21-23, 2020. This company market capitalization has remained high, hitting $90.45 million at the time of writing.

    Illumina Inc. (NASDAQ: ILMN)

    Illumina Inc. (NASDAQ: ILMN) shares headed falling, lower as much as -0.60%. The most recent rating by UBS, on September 22, 2020, is at a Neutral. Illumina Inc. (ILMN) has officially revealed an agreement to buy cancer-testing company Grail for about $8 billion in cash and stock. This company market capitalization has remained high, hitting $39.54 billion at the time of writing.

    Precipio Inc. (NASDAQ: PRPO)

    Precipio Inc. (NASDAQ: PRPO) shares headed rising, higher as much as 2.63%. Precipio Inc. has revealed that it has introduced its HemeScreen AML (Acute Myeloid Leukemia) panel both clinically in its CLIA laboratory, and as part of its HemeScreen product offering. This company market capitalization has remained high, hitting 37.42 million at the time of writing.

    Fulgent Genetics Inc. (NASDAQ: FLGT)

    Fulgent Genetics Inc. (NASDAQ: FLGT) stock soar by 7.08% to $40.25. The most recent rating by Oppenheimer, on August 20, 2020, is at an Outperform. Fulgent Genetics Inc. (FLGT) will replace Garrett Motion Inc. (GTX) in the S&P SmallCap 600 effective before the opening of trading on Friday, September 25. This company’s market capitalization has remained high, hitting $821.10 million at the time of writing.

    Fluidigm Corporation (NASDAQ: FLDM)

    Fluidigm Corporation (NASDAQ: FLDM) fall -1.29% after losing more than -$0.11 on Tuesday. In the past 52-weeks of trading, this company’s stock fluctuated between the low range of $1.17 and a high range of $12.45. It has moved up 595.73% from its 52-weeks low and moved down -34.62% from its 52-weeks high. Looking at its liquidity it has a current ratio of 2.00. This company’s market capitalization has remained high, hitting $523.91 million at the time of writing.

    Invitae Corporation (NYSE: NVTA)

    Invitae Corporation (NYSE: NVTA) last closed at $43.10, in a 52-week range of $7.41 to $40.96. Analysts have a consensus price target of $36.25. Invitae Corporation (NVTA) has moved up 475.19% from its 52-weeks low and moved down -2.16% from its 52-weeks high. Looking at its liquidity it has a current ratio of 3.70. This company’s market capitalization has remained high, hitting $5.56 billion at the time of writing.

    HTG Molecular Diagnostics Inc. (NASDAQ: HTGM)

    HTG Molecular Diagnostics Inc. (NASDAQ: HTGM) fall -8.01% after losing more than -$0.03 on Tuesday. HTG Molecular Diagnostics Inc. (HTGM) share price went from a low point around $0.27 to briefly over $0.99 in the past 52 weeks, though shares have since pulled back to $0.32. HTG Molecular Diagnostics Inc. market cap has remained high, hitting $22.70 million at the time of writing

    Co-Diagnostics Inc. (NASDAQ: CODX)

    Co-Diagnostics Inc. (NASDAQ: CODX) last closed at $14.93, in a 52-week range of $0.85 to $30.99. Co-Diagnostics Inc. (CODX) has moved up 1567.08% from its 52-weeks low and moved down -54.47% from its 52-weeks high. Looking at its liquidity it has a current ratio of 11.60. This company’s market capitalization has remained high, hitting $404.90 million at the time of writing.

  • 3 Top Performing Stocks to Watch This Morning: Biotech and Energy Stocks Lead the Way

    3 Top Performing Stocks to Watch This Morning: Biotech and Energy Stocks Lead the Way

    The key stock market indices are down today as the market awaits earnings news and the growing tensions between the U.S and China. Today, China has made a statement against the U.S decision to close the Chinese consulate in Houston, stating that it would take countermeasures against the move by the U.S. The flare-up of tensions between the two countries amidst an ongoing pandemic is reeling the markets. Nonetheless, there are stocks that are gaining strongly ahead of market opening. Most of the big movers pre-market are biotech and energy stocks. Some of the big movers at the moment are as below:

    Bionano Genomics Inc [NASDAQ:BNGO]

    Bionano Genomics Inc [BNGO] is a big mover pre-market and is up by 18% and gaining. BNGO stock has been gaining momentum driven by two recent developments on its biotech projects. Yesterday, Bionano Genomics Inc announced that an international consortium spearheaded by Laila El Khattabi of the Cochin Hospital in France had published a paper touching on the use of Bionano’s Saphyr Genome Imaging instrument. This was with regard to testing the performance of Bionano’s data when compared to the cytogenetic standard of care in the treatment of inherited genetic disorders. The team found that Bionano’s Saphyr was able to detect all; chromosomal aberrations in a total of 85 samples. The positive news came just a few days after BNGO announced that its data is a key part of the first-ever full assembly of a human being’s X-chromosome.  With such positive developments, the momentum around BNGO stock is on the rise even as the rest of the market looks shaky ahead of Mid-week trading.

    Zomedica Pharmaceuticals Corp [NYSE:ZOM]

    Zomedica Pharmaceuticals Corp [ZOM] is another top performer in pre-market trading and is up by 16% at the moment. This follows the ZOM announcement that it had successfully installed TRUFORMA™ remotely. This is a point-of-care diagnostic device that has allowed the company to go ahead with test validation. The  CEO has stated that ZOM is focused on making TRUFORMA™ available in the market soon.

    TransAtlantic Petroleum Ltd [NYSE:TAT]

    This is another top gainer ahead of market opening and is up by 78% pre-market. TransAtlantic Petroleum Ltd [TAT] has been on the rise since it reported financial results for Q1 of 2020. TransAtlantic Petroleum Ltd reported that revenues were down due to the decrease in oil prices. It also added that its hedge at the time was for an oil price of $36 a barrel. Like most energy prices, TAT stock has been buoyed by the increase in oil prices, and its current price action is among the best in the market. Its strong position is also driven by the fact that it was in good cash flow even during the time when oil was at its lowest.